Marek Postula (@marekpostula) 's Twitter Profile
Marek Postula

@marekpostula

Longevity cardiologist

ID: 1173650911908028418

calendar_today16-09-2019 17:32:52

49 Tweet

82 Followers

100 Following

I-COMET (@icomet_team) 's Twitter Profile Photo

Our review discussing the role of #platelets in liver fibrosis and accompanying hemostatic disorders together with the role of antiplatelet drugs in liver disorders is out! #antiplatelettreatment #liverfibrosis Marek Postula Ceren Eyileten tandfonline.com/eprint/CADWNIX…

Our review discussing the role of #platelets in liver fibrosis and accompanying hemostatic disorders together with the role of antiplatelet drugs in liver disorders is out!  
#antiplatelettreatment
#liverfibrosis
<a href="/MarekPostula/">Marek Postula</a> <a href="/cereneyileten/">Ceren Eyileten</a>
tandfonline.com/eprint/CADWNIX…
I-COMET (@icomet_team) 's Twitter Profile Photo

Our review discussing #miRNAs and #lncRNA in the context of DM, and the contribution of pathophysiological mechanisms incl #inflammatory response, oxidative stress, #apoptosis, #hypertrophy and #fibrosis to the development of #DCM is online! cardiab.biomedcentral.com/articles/10.11… #ICOMET

Our review discussing #miRNAs and #lncRNA in the context of DM, and the contribution of pathophysiological mechanisms incl #inflammatory response, oxidative stress, #apoptosis, #hypertrophy and #fibrosis to the development of #DCM is online!

cardiab.biomedcentral.com/articles/10.11…

#ICOMET
I-COMET (@icomet_team) 's Twitter Profile Photo

Prof. Marek Postula takes part in HFA course in clinical trials by ESC in Sorrento. I-COMET team members are working hard to guide SGLT2 inhibitors treatment for personalized therapy in heart failure #neverstoplearning #neverfollowslwayslead #EMPATHYTRIAL #EMMYTRIAL #ICOMET

Prof. <a href="/MarekPostula/">Marek Postula</a> takes part in HFA course in clinical trials by ESC in Sorrento. I-COMET team members are working hard to guide SGLT2 inhibitors treatment for personalized therapy in heart failure #neverstoplearning #neverfollowslwayslead #EMPATHYTRIAL #EMMYTRIAL #ICOMET
Senolytic Biotech (@senolyticbio) 's Twitter Profile Photo

Aging may not be due to build-up of mutations alone, study suggests news-medical.net/news/20210929/… #Longevity #Lifespan #Ageing

Aging may not be due to build-up of mutations alone, study suggests

news-medical.net/news/20210929/…

#Longevity #Lifespan #Ageing
Marek Postula (@marekpostula) 's Twitter Profile Photo

I-COMET team is entering a new area of scientific interest to better predict CV outcomes based on complex risk score. Precision medicine based on new biomarkers #ncRNA #micorbiota #proteome #metabolome is future of cardiology and prevention. #icometteam frontiersin.org/articles/10.33…

Marek Postula (@marekpostula) 's Twitter Profile Photo

Sirtuin signaling pathway plays a crucial role in aging. I-COMET team is testing hypothesis that SGLT2 inhibitors may act on SIRT gene interaction network and thus have ani-aging effect. #icometteam #neverfollowalwayslead #precisionmedicine #antiageing wyborcza.pl/7,75400,277927…

Salvatore De Rosa (@saderosa78) 's Twitter Profile Photo

Circulating #MiRNA mark adverse #cardiovascular response to strenuous #excercise! Thanks to the polish partner and the I-COMET for the chance to collaborate! Read the whole story on frontiersin.org/article/10.338… #CardioTwitter Marek Postula MD, PhD Ceren Eyileten

Frontiers - Pharmacology and Toxicology (@frontpharmacol) 's Twitter Profile Photo

We have just launched an exciting #OpenAccess Research Topic on #pharmacogenomics and #pharmacogenetics of cardiovascular/neurovascular disorders! 🫀🧠 📆6th July 2022 Interested? Learn more here ➡️ fro.ntiers.in/34880

We have just launched an exciting #OpenAccess Research Topic on #pharmacogenomics and #pharmacogenetics of cardiovascular/neurovascular disorders! 🫀🧠

📆6th July 2022

Interested? Learn more here ➡️ fro.ntiers.in/34880
Salvatore De Rosa (@saderosa78) 's Twitter Profile Photo

#FDA gives green light ti #Mounjaro, Dual-Action inhibitor: GLP-1 and GIP receptors. Exciting times ahead for CV #prevention in #diabetes!

Jolanta SillerMatula, MD PhD (@jsillermatula) 's Twitter Profile Photo

We are thrilled to share with you that the results of the EMMY trial are published #ESCCongress #EHJ. EMPAGLIFLOZIN administered immediately post large MI with #PCI improved: - NT-proBNP levels and - markers of cardiac structure and function academic.oup.com/eurheartj/adva…

We are thrilled to share with you that the results of the EMMY trial are published #ESCCongress #EHJ.
 
EMPAGLIFLOZIN administered immediately post large MI with #PCI improved:
- NT-proBNP levels and
- markers of cardiac structure and function

academic.oup.com/eurheartj/adva…
Eric Topol (@erictopol) 's Twitter Profile Photo

Vigorous intermittent lifestyle physical activity (VILPA), 3-4 minute bursts per day, associated with ~40% reduction of all-cause mortality, cancer and cardiovascular mortality nature.com/articles/s4159… Nature Medicine Mark Hamer Emmanuel (Manos) Stamatakis

Vigorous intermittent lifestyle physical activity (VILPA), 3-4 minute bursts per day, associated with ~40% reduction of all-cause mortality, cancer and cardiovascular mortality nature.com/articles/s4159… <a href="/NatureMedicine/">Nature Medicine</a>  <a href="/ma_hamer/">Mark Hamer</a> <a href="/M_Stamatakis/">Emmanuel (Manos) Stamatakis</a>